R&D Partner Content 7th TPD & Induced Proximity Summit Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address
R&D Partner Content 5th Gene Therapy Immunogenicity Summit Optimise Safety & De-Risk Efficacy of Viral Vector Based Gene Therapies
R&D Partner Content 2nd CRISPR-Based Therapy Analytical Development Summit Fostering Analytical Gold Standards for Genome Editing Therapies
R&D Partner Content 3rd Lipid Nanoparticles Development Summit Europe Unlock LNP potential with enhanced clinical translatability at the 3rd Lipid Nanoparticles Development Summit Europe (24-26 September, Berlin, Germany), the leading dedicated LNP f
R&D Partner Content ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summi... Collaborate, license, and partner to reduce risks, validate technologies, and acquire clinically ready assets
R&D Partner Content 6th Gene Therapy Analytical Development & CMC Summit Execute Robust Analytical & Process Development Strategies for Complex Gene Therapies
News Novartis CEO joins board of "responsible" AI firm Anthropic In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.